2.835USD-7.65%Mkt Cap: 573.06M USDP/E: —Last update: 2026-06-01
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The company offers INTERCEPT Blood System, a propriet…
Industry Peers
Medical Devices152.01BUSDP/E 24.4
115.59BUSDP/E 34.9
71.08BUSDP/E 20.0
54.41BSEKP/E 101.6
52.05BDKKP/E 22.0
51.03BUSDP/E 47.9
50.55BSEKP/E 21.4
38.34BEURP/E 18.1
Indicators:|
Key Statistics
Company
Market Cap573.06M USD
Enterprise Value626.79M USD
Revenue (TTM)216.56M USD
Gross Profit112.29M USD
Net Income (TTM)-15.63M USD
Revenue/Share1.126 USD
Last Price2.835 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees261
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)Infinity
PEG—
EV/EBITDA-387.86
EV/Revenue2.89
P/S2.81
P/B9.02
EPS (TTM)-0.05
EPS (Forward)0.00
52W Range
1.15084% of range3.150
52W High3.150 USD
52W Low1.150 USD
Profitability
Gross Margin54.47%
Oper. Margin-0.66%
EBITDA Margin-0.75%
Profit Margin-7.58%
ROE-24.33%
ROA-7.04%
Growth
Revenue Growth24.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF4.84M USD
CapEx (TTM)3.73M USD
FCF Margin1.04%
FCF Yield0.39%
Net Debt16.93M USD
Net Debt/EBITDA-10.48
Balance Sheet
Debt/Equity1.51
Current Ratio1.63
Quick Ratio1.02
Book Value/Sh0.3370 USD
Cash/Share0.4010 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)4.667 USD
Target Range4.000 USD – 5.000 USD
# Analysts3
Ownership
Shares Out.200.37M
Float182.21M
Insiders3.24%
Institutions74.64%
Short Interest
Short Ratio6.6d
Short % Float9.52%
Short % Out.9.24%
Shares Short18.52M
Short (prev mo.)11.20M
Technical
SMA 502.177 (+30.2%)
SMA 2001.906 (+48.8%)
Beta1.63
S&P 52W Chg27.94%
Avg Vol (30d)2.73M
Avg Vol (10d)2.47M
Technical Indicators
RSI (14)74.7
MACD0.1881
MACD Signal0.1627
MACD Hist.+0.0254
BB Upper2.968 USD
BB Middle2.652 USD
BB Lower2.337 USD
BB Width23.77%
ATR (14)0.1792 USD
Vol Ratio (20d)0.51x